手术件数排名:
(2013年.数据来源为读卖新闻医疗部出具的手术件数。)
胃癌全国第一
大肠癌全国第一
乳癌全国第一
前列腺癌全国第二
肝癌全国第二
肺癌全国第五。
医院简介:
癌研有明医院作为癌症专科医院,积极引进国际上最先进的治疗方法,拥有世界上尚为数不多的诊断和治疗技术。根据患者的病情采用集学治疗,即组合采用外科治疗、放射治疗、化疗等诊治各种类型的癌症,治疗和诊断技术水准都处于世界领先地位。该院将内科、外科、放疗、放射线诊断、病理各科专家及医务助理组成团队,共同研究患者的特点和情况,制定最佳治疗方案。根据患者具体情况选择和组合治疗方式,提供“团队医疗”,让每位患者在治疗全程中获得最大疗效。
医院的发展历史:
80年前,作为日本唯一的癌症专科医院,从最初的只有29张病床,到如今发展为拥有700张病床的现代化医院。今后,癌研有明医院仍将在持续提供高技术的癌症诊断和治疗的同时,努力推动最先进的癌症临床研究。
重点科室:
癌研有明的诊疗部分总的来说有三个部分,分别是:专门诊疗部门,一般诊疗部门,以及中央诊疗部门。每个部门下有包括各个科室。
专门诊疗部门下包括:呼吸科,消化科,乳腺科,妇科,头颈科,整形外科,泌尿科,血液肿瘤科,综合肿瘤科,肉瘤中心,免疫・遗传基因诊疗科。
一般诊疗部门下包括:综合内科,麻醉科,整形外科,眼科,传染病科,皮肤科,汉方药科,牙科。
中央诊疗部门下包括:缓和治疗中心(中心下辖缓和治疗科,癌症疼痛治疗科,肿瘤精神科,缓和治疗组,癌症咨询支援中心,WOC支援室,医疗协作部),放射线治疗部,画像诊断中心,内视镜诊疗部,化学疗法部,遗传基因诊疗部,中央手术部,集中治疗部,急救部,康复部,临床检查中心,输血部,临床病理中心,营养管理部,灭菌材料室,ME中心,摄影中心。
注:WOC是Wound(创伤),Ostomy(造瘘术),Continence(失禁)三个英文词汇的首字母缩写。
ME是Medical Engineering(临床工学)的首字母缩写。
癌研有明医院English网站 http://www.jfcr.or.jp/english/about/index.html
医院官网介绍:
Japanese Foundation for Cancer Research (JFCR) was established in 1908 as the first institute in Japan specialized in cancer. Since the establishment of the Cancer Institute and its affiliated hospital, JFCR has been leading the researches and treatments of cancer in Japan through the activities integrating basic and clinical researches. You may find many references such as “the first in Japan...” or “the largest number in Japan…” in the introduction of JFCR. This proves our achievements in the field of cancer research and treatment in our long history.
Especially, remarkable results are made in research field in recent years, and JFCR is appreciated as one of the world top class institutes in bioscience in the article run by US magazine “The Science” in its recent issue featuring “Science in Japan.”
At the affiliated hospital, JFCR has been making achievements in treatments of cancer and its related diseases with highly efficient medical staffs and leading-edge medical equipments. At the same time, the Cancer Institute Hospital actively works on developing new method of treatments by clinical research cooperating closely with Cancer Institute.
In January 2001, JFCR had the honor of receiving His Imperial Highness Prince Hitachi, who had been engaged in research of animal cancer for long time as a visiting professor, as Honorary President. JFCR is on at its new stage now.